340O Efficacy, safety and biomarker analysis of ICARUS-BREAST01: A phase II study of patritumab deruxtecan (HER3-DXd) in patients (pts) with HR+/HER2- advanced breast cancer (ABC)

Barbara Pistilli, Luisa Pierotti, M. Lacroix-Triki, Cécile Vicier, Jean‐Sébastien Frenel, Véronique D’Hondt, F. Dalenc, T. Bachelot, Agnès Ducoulombier, M-A. Benderra, D. Loirat, Didier Mayeur, Ghada Nachabeh, Andrea Sporchia, Fumitaka Suto, Stefan Michiels, Noémie Corcos, M.F. Mosele, Fabrice André, Guillaume Montagnac